Hope for VHL patients: Long-Term belzutifan trial tracks survival
NCT ID NCT07405164
First seen Feb 13, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study is for people already taking belzutifan in another trial for advanced solid tumors or von Hippel-Lindau (VHL) disease. Belzutifan blocks a protein that helps tumors grow. The goal is to see how long people live and track any side effects over time. About 450 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON HIPPEL LINDAU DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center ( Site 2900)
RECRUITINGSeoul, 05505, South Korea
Contact Phone: •••-•••-••••
-
CNCE Precarpathian Clinical Oncologic Center ( Site 2600)
ACTIVE_NOT_RECRUITINGIvano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine
-
ME І.І. Mechnykov Dnipro Regional Clinical Hospital ( Site 2601)
ACTIVE_NOT_RECRUITINGDnipropetrovsk, Dnipropetrovsk Oblast, 49005, Ukraine
-
N.N. Blokhin NMRCO ( Site 2101)
RECRUITINGMoscow, Moscow, 115478, Russia
Contact Phone: •••-•••-••••
-
Rambam Health Care Campus ( Site 1600)
RECRUITINGHaifa, 3109601, Israel
Contact Phone: •••-•••-••••
-
Russian Scientific Center of Radiology and Surgical Technologies ( Site 2100)
ACTIVE_NOT_RECRUITINGSaint Petersburg, Sankt-Peterburg, 197758, Russia
-
START San Antonio ( Site 0104)
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Phone: •••-•••-••••
-
Samsung Medical Center ( Site 2902)
RECRUITINGGangnam, Seoul, 06351, South Korea
Contact Phone: •••-•••-••••
-
Severance Hospital, Yonsei University Health System ( Site 2901)
RECRUITINGSeodaemun-gu, Seoul, 03722, South Korea
Contact Phone: •••-•••-••••
-
Sourasky Medical Center ( Site 1603)
RECRUITINGTel Aviv, 64239, Israel
Contact Phone: •••-•••-••••
-
Taipei Veterans General Hospital ( Site 2800)
RECRUITINGTaipei, 11217, Taiwan
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.